What CARSO Pharma does

CARSO Pharmaceutique (also known as CARSO LSEHL) is the pharmaceutical analytical testing subsidiary of Groupe CARSO Holding, a French laboratory group founded in 1992 and headquartered at a ~10,000-15,000 m² facility in Lyon-Vénissieux, France. The company operates as an ANSM-authorized pharmaceutical establishment providing quality control testing services to manufacturers in four verticals: pharmaceuticals, cosmetics, medical devices, and nutraceuticals. Its service portfolio spans six integrated disciplines - microbiology (microbial contamination, sterility under isolator, endotoxin, MALDI-TOF/VITEK 2 identification), physico-chemistry (raw material and finished product testing per pharmacopoeias, residual solvents, elemental impurities per ICH Q3D), analytical development (ICH Q2 method validation, nitrosamine studies), environment and water (purified/WFI/PPI water qualification, cleaning validation), stability studies (ICH-conditioned climatic chambers), and molecular biology - delivered through a 24/7 operational model on BPF/cGMP-certified and COFRAC ISO 17025-accredited infrastructure. A notable sub-specialty is nitrosamine genotoxic impurity analysis, with 350+ projects completed since 2020 across 400+ matrices using LC-MS/MS, LC-HRMS, and GC-MS/MS at sub-ppb detection under EMA/FDA frameworks.

The business model is professional-services B2B with personalized account engagement and dedicated client teams. Revenue is generated through per-test analytical services, on-site sampling engagements, and integrated pharmaceutical QC programs; pricing is not publicly disclosed and is handled through direct quotation. Equipment platform includes LC-MS/MS, GC-MS/MS, LC-HRMS, HRGC-HRMS, ICP-MS, MALDI-TOF, VITEK 2, ion chromatography, climatic chambers, and sterility isolators. CARSO Pharmaceutique operates as a wholly owned subsidiary of GROUPE CARSO HOLDING (RCS Lyon B 823 802 285), which since 2021 has had healthcare-focused private equity fund ArchiMed as majority shareholder. Group-wide scale reaches 2,500 employees (including 500 engineers/PhDs and 1,900 specialized technicians), 40,000 m² of analytical surface, and 30-50 million parameters analyzed annually across 30+ French and 10+ international locations.

Name

CARSO Pharma

Legal name

GROUPE CARSO HOLDING

Website

https://carso-pharmaceutique.fr

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

1–10 employees

Short description

CARSO Pharmaceutique is the ANSM-authorized pharmaceutical analytical testing subsidiary of French laboratory group Groupe CARSO, providing BPF/cGMP-certified quality control services in microbiology, physico-chemistry, nitrosamines, stability, and water analysis to pharmaceutical, cosmetic, medical device, and nutraceutical manufacturers at its Lyon-Vénissieux platform.

Ownership category

akta.pro rank

Product category

Pharmaceutical Analytical Testing Services

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Manufacturing Quality Assurance & GMP Compliance (batch release, deviation/CAPA, tech transfer QA) (HLAGAKAJ)

akta.pro secondary industries

GMP Manufacturing Support Services (QA/QMS, validation, documentation) (HLAAAKAH), CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD), Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)

Keywords

• Pharmaceutical analytical testing
• Quality control services
• Microbiological testing
• Physico-chemical analysis
• Stability studies

Headquarters

HQ city

Lyon-Vénissieux

HQ country

France

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Analytical Testing Services: Laboratory analysis and expertise services for pharmaceutical, cosmetic, medical device, and nutraceutical industries. Services cover the complete product lifecycle from development through routine quality control.
2. On-site Sampling and Sample Collection: Field services including on-site sampling and sample collection, with laboratory analysis performed at the facility.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

CARSO Pharmaceutique is the pharmaceutical entity of CARSO LSEHL, an ANSM-authorized pharmaceutical establishment providing analytical testing and quality control services for the pharmaceutical, cosmetic, medical device, and nutraceutical industries. Operations are anchored at the Lyon-Vénissieux platform with a 10,000 m² laboratory footprint (recently extended by 3,000 m²) and include microbiology, physico-chemistry, analytical development, environment and water analysis, stability studies, molecular biology, and on-site sampling services delivered under BPF/cGMP and COFRAC ISO 17025 accreditation.

Product overview

CARSO Pharmaceutique operates as a comprehensive analytical testing platform serving the pharmaceutical, cosmetic, nutraceutical, and medical device industries. Its service portfolio spans six interconnected analytical disciplines — Microbiology, Physicochemistry, Analytical Development, Environment and Water, Stability Studies, and Molecular Biology — each supported by ANSM-authorized pharmaceutical establishment operations and BPF/cGMP compliance. The Nitrosamines sub-service is a specialized offering under the Physicochemistry umbrella, addressing genotoxic impurity testing for EMA/FDA regulatory compliance. All services are delivered through a 24/7 operational model at the Lyon-Vénissieux site, with unified quality management and COFRAC ISO 17025 accreditation underpinning the full offering.

Differentiator

Problem solved

Functional benefit

Products and services

• Microbiology Pharmaceutical microbiology services covering microbial contamination control, specified germ testing, sterility testing under isolator, antimicrobial preservation efficacy (challenge tests), bacterial endotoxin quantification, MALDI-TOF and VITEK 2-based bacterial and fungal identification, and environmental air and surface monitoring for pharmaceutical and cosmetic manufacturers.
• Physico-chemical Analysis Quality control of active ingredients, raw materials, bulk and finished products per pharmacopoeias, including residual solvents, nitrosamines, pesticides, ethylene oxide and dioxane, heavy metals and elemental impurities (ICH Q3D), UV filter assays, preservative assays, Karl Fischer titration, and IR spectroscopy for pharmaceutical and cosmetic producers.
• Nitrosamine Analysis Specialized genotoxic impurity analysis including risk evaluation, confirmatory testing by LC-MS/MS, LC-HRMS, and GC-MS/MS with detection below ppb per EMA/FDA, NDSRI screening, and water and precursor screening; over 350 nitrosamine projects managed since 2020 across 400+ different matrices.
• Analytical Development Method development and validation under ICH Q2 guidelines, nitrosamine impurity studies, and contaminant and impurity profiling for pharmaceutical, cosmetic, and health products.
• Environment and Water Analysis Pharmaceutical water qualification and monitoring (purified water, WFI, PPI) per European, USP, and Chinese Pharmacopoeias; visible and subvisible particle analysis; environmental air and surface control; and cleaning validation including analytical method validation and recovery rate confirmation.
• Stability Studies Stability studies in climate-controlled chambers under ICH conditions (25°C/60% RH, 30°C/65% RH, 40°C/75% RH), with storage-only or storage-plus-analysis services per client specifications.
• Molecular Biology Molecular biology analytical services supporting pharmaceutical quality control applications, offered as part of the CARSO Pharmaceutique service portfolio.
• Ecotoxicology Ecotoxicology analytical services addressing environmental and regulatory testing requirements for health products, delivered in conjunction with the broader Groupe CARSO environment and water division.

Quantifiable outcome

• +350 nitrosamine projects managed since 2020
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Five partnerships are on record, tiered core and major.

• ANSM (Agence nationale de sécurité du médicament et des produits de santé)coreOthersRegulatory authorization body for pharmaceutical establishments in France. CARSO Pharmaceutique holds ANSM authorization (Decision 2022_242_1_2 for Vénissieux site, Decision F 19_111 for Neuilly-en-Thelle) for pharmaceutical establishment activities limited to quality control testing for human and experimental drugs.
• EMA (European Medicines Agency)coreOthersEuropean Medicines Agency maintains Eudra GMP database containing certificates of GMP compliance. CARSO BPF certification is verifiable through Eudra GMP system.
• COFRAC (Comité Français d'Accréditation)coreOthersFrench accreditation body providing ISO 17025 accreditation for testing and calibration laboratories. CARSO holds COFRAC accreditation demonstrating technical competence.
• Groupe CARSOcoreOthersParent company of CARSO Pharmaceutique. Groupe CARSO develops proximity with clients through extensive presence across French territory and internationally, with 40+ locations. Group revenue of 230 M€ with 2,500 employees including 400 engineers and PhDs. CARSO Pharmaceutique is the pharmaceutical entity within the group.
• A3P (Association for Pharmaceutical Production)majorStrategic or Co-development PartnerA3P federates international network of expertise for pharmaceutical, bioproduction, and cosmetic industries. CARSO Pharmaceutique actively participates in A3P events including Cosmetic (June 11), Microbiologie (June 24-25), and International Congress (October 13-15). Events focus on anticipating regulatory developments, exchanging with analytical experts, and building durable partnerships.

Scale indicators10 records

Recent moves12 records

Expansion highlights6 records

Direct peers

• ALS Limited: International testing services group with Life Sciences division providing pharmaceutical, environmental, and food testing. Similar analytical service portfolio to CARSO Pharmaceutique, with comparable focus on regulated industry testing and method validation.
• Ardena: European contract analytical and CDMO services for pharmaceutical companies, offering method development, validation, stability, and GMP release testing. Similar size and positioning to CARSO Pharmaceutique with comparable service portfolio for pharma clients across Europe.
• Mérieux NutriSciences (bioMérieux subsidiary): Contract analytical testing for food, pharmaceutical, and cosmetic industries. Strong overlap in microbiology, physico-chemical analysis, and stability testing with CARSO Pharmaceutique, with similar B2B service model serving regulated industries.
• EAG Laboratories (Eurofins): Materials science and pharmaceutical testing services including impurity analysis, extractables/leachables, and nitrosamine testing. Closely comparable specialty in genotoxic impurity and nitrosamine analysis that overlaps directly with CARSO Pharma's differentiated nitrosamine offering.
• Nelson Laboratories (Sotera Health): Pharmaceutical and medical device laboratory testing services with focus on microbiology, chemistry, and packaging testing. Directly comparable analytical testing services for pharmaceutical and medical device manufacturers, serving as a strong peer in CARSO's core verticals.

Broad incumbents

• Eurofins Scientific: Global leader in bioanalytical and pharmaceutical testing services. Direct overlap in pharma QC, microbiological testing, stability studies, and method validation. Far larger scale and geographic reach, but CARSO Pharma competes for similar pharmaceutical clients with comparable analytical offerings.
• SGS SA: Global testing, inspection, and certification company with a Life Sciences division offering pharmaceutical analytical testing, stability, and regulatory support. Comparable service portfolio but operates at vastly greater international scale than CARSO Pharmaceutique.
• Intertek Group: Testing and quality assurance provider with pharmaceutical and healthcare services including analytical testing, GMP compliance, and stability storage. Comparable contract analytical model and customer base as CARSO Pharmaceutique, with broader global footprint.
• Charles River Laboratories: Pharmaceutical services and contract research organization offering analytical method development, validation, batch release testing, and stability studies. Direct overlap with CARSO Pharma's core offering for pharmaceutical manufacturers, though broader preclinical and manufacturing services portfolio.

Emerging players

• Concept Life Sciences: UK-based contract research and analytical services organization providing pharmaceutical testing, impurity profiling, and method development. Comparable European-based CRO/analytical testing positioning with overlap in pharmaceutical QC and analytical development services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/carso-pharma

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CARSO Pharma